Related Experiment Videos
Melatonin state in Mendenhall's syndrome
C D Rittey1, T J Evans, C E Gray
1Royal Hospital for Sick Children, Yorkhill, Glasgow.
Archives of Disease in Childhood
|July 1, 1988
Summary
Mendenhall's syndrome can present as hypoglycemia. This case study reveals elevated urinary melatonin metabolites, suggesting disrupted pineal gland function in this rare disorder.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Rare Diseases
Background:
- Mendenhall's syndrome is a rare genetic disorder characterized by insulin resistance, lipodystrophy, and growth retardation.
- Hypoglycemia is an atypical presentation for Mendenhall's syndrome, which is more commonly associated with hyperglycemia.
- Understanding the metabolic and endocrine disturbances in Mendenhall's syndrome is crucial for diagnosis and management.
Observation:
- A case of Mendenhall's syndrome is presented with hypoglycemia as the primary clinical manifestation.
- Detailed clinical and biochemical features of the patient were documented.
- For the first time, studies on the patient's melatonin status were conducted.
Findings:
- The patient exhibited hypoglycemia, an unusual presentation for Mendenhall's syndrome.
- Urinary analysis revealed elevated levels of melatonin metabolites.
- This finding suggests potential disordered pineal gland function in Mendenhall's syndrome.
Implications:
- This case expands the known clinical spectrum of Mendenhall's syndrome.
- The elevated melatonin metabolites suggest a potential link between pineal function and metabolic derangements in this syndrome.
- Further research into pineal gland function may offer new diagnostic or therapeutic avenues for Mendenhall's syndrome.